Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Safety and Pharmacokinetic Study of Subcutaneous ALXN1720 in Participants With Proteinuria

Alexion Pharmaceuticals, Inc. · 2022
ClinicalTrials.gov · Datasets · License: Public Domain · 2022
Open Source ↗
chronic-kidney-diseasediabetic-nephropathy
proteinuria, glomerular disease, chronic kidney disease, lupus nephritis, immunoglobulin a nephropathy, primary membranous nephropathy, focal segmental glomerulosclerosis, diabetic nephropathy, hypertensive nephrosclerosis, minimal change disease, thin basement membrane nephropathy, membranoproliferative glomerulonephritis (all forms)
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 882228
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.